{"text": ["Pfizer-Lilly", "non-opioid", "drug", "helps", "reduce", "osteoarthritis", "pain"], "created_at": "2018-10-23 22:40:01"}
{"text": ["Complete", "Results", "from", "First", "Study", "in", "Ongoing", "Phase", "3", "Program", "for", "Tanezumab", "Demonstrated", "Significant", "Improvement", "in", "Pain", "and", "Function", "in", "Osteoarthritis", "Patients"], "created_at": "2018-10-23 22:40:00"}
{"text": ["This", "IBD", "Stock", "Of", "The", "Day", "Is", "Heading", "For", "Fourth", "Quarter", "Of", "Profitability"], "created_at": "2018-10-23 20:41:48"}
{"text": ["Notable", "ETF", "Inflow", "Detected", "-", "XLV,", "LLY,", "BMY,", "CVS"], "created_at": "2018-10-23 16:11:19"}
{"text": ["Notable", "ETF", "Inflow", "Detected", "-", "XLV,", "LLY,", "BMY,", "CVS"], "created_at": "2018-10-23 16:11:19"}
{"text": ["How", "Is", "Novartis", "Valued?"], "created_at": "2018-10-23 14:30:53"}
{"text": ["See", "what", "the", "IHS", "Markit", "Score", "report", "has", "to", "say", "about", "Eli", "Lilly", "And", "Co."], "created_at": "2018-10-23 12:00:41"}
{"text": ["Investor", "Expectations", "to", "Drive", "Momentum", "within", "Navios", "Maritime", "Partners", "LP,", "Alliance", "Data,", "Eli", "Lilly,", "CONVERGEONE", "HLD,", "Atkore", "International", "Group,", "and", "NantKwest", "\u2014", "Discovering", "Underlying", "Factors", "of", "Influence"], "created_at": "2018-10-23 12:00:00"}
{"text": ["Why", "Nektar", "Therapeutics", "Crashed", "17.2%", "Today"], "created_at": "2018-10-23 00:07:39"}
{"text": ["Why", "Nektar", "Therapeutics", "Crashed", "17.2%", "Today"], "created_at": "2018-10-23 00:07:39"}
